For Researchers

The COVID-19 biorepository has been established to create a central repository of blood and other specimen types from people infected with SARS-CoV2 with accompanying de-identified health information. 

The COVID-19 comprehensive database houses de-identified information on all people tested for COVID-19 at Tufts Medical Center.

The COVID-19 biorepository has been designed to support prospective collection of biospecimens and associated de-identified data under one standardized protocol. The centralized nature of the biobank will ensure uniform specimen handling, data quality, and regulatory oversight for biobanking operations. 

The COVID-19 biorepository is available to qualified investigators within the Tufts Medical Center and Tufts University research community. A limited number of specimens and de-identified data will be shared with the Massachusetts Consortium on Pathogen Readiness (Mass CPR).

Make a formal request: You plan to request specimens from COVID-19 infected people (and or negative controls) and accompanying de-identified data. Before making your request,  you must have all  approvals in place (e.g., IRB approval, relevant COVID-19 Research Oversight Committee approval and Institutional Biosafety Committee (IBC) approval). If you are making a request for specimens and data, there is no need to compete a request for de-identified data only.

Make a formal request: You plan to request de-identified data (no specimens) from people tested for COVID-19. Before making your request, you must have all approvals in place (e.g., IRB and relevant COVID-19 Research Oversight Committee).

We adhere to all federal, state and local regulations regarding the use of bio-samples and de-identified data for human subject’s research.